PALISADE BIO, INC. - PALI

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$261.7M
QoQ value delta ($000)
-$57.66M (-18.05%)
Implied price effect (QoQ)
-25.15%
Shares
Total shares
148,804,637
QoQ shares delta
+12,895,043 (+9.49%)
Total shares held by funds (by quarter)

Market chart (PALI)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 96 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
B Group, Inc. 19,974 11,414,285 14.81%
JANUS HENDERSON GROUP PLC 18,759 10,689,452 0.01%
Octagon Capital Advisors LP 17,983 10,276,317 1.99%
PERCEPTIVE ADVISORS LLC 15,624 8,928,149 0.31%
AMERIPRISE FINANCIAL INC 15,244 8,711,385 0.0%
Commodore Capital LP 12,566 7,181,062 0.73%
RA CAPITAL MANAGEMENT, L.P. 12,467 7,124,116 0.13%
FRANKLIN RESOURCES INC 10,124 5,785,189 0.0%
GOLDMAN SACHS GROUP INC 9,404 5,373,951 0.0%
Eversept Partners, LP 8,728 4,987,499 0.46%
Boxer Capital Management, LLC 8,399 4,799,875 1.1%
MORGAN STANLEY 7,965 4,551,533 0.0%
ADAGE CAPITAL PARTNERS GP, L.L.C. 7,875 4,500,000 0.01%
GREAT POINT PARTNERS LLC 5,960 3,405,757 1.37%
BALYASNY ASSET MANAGEMENT L.P. 5,723 3,270,845 0.01%
FEDERATED HERMES, INC. 5,489 3,136,607 0.01%
Squadron Capital Management LLC 5,250 3,000,000 1.92%
WELLINGTON MANAGEMENT GROUP LLP 5,083 2,904,911 0.0%
VANGUARD GROUP INC 4,971 2,115,622 0.0%
MARSHALL WACE, LLP 4,820 2,754,403 0.0%
Vestal Point Capital, LP 4,375 2,500,000 0.12%
ORBIMED ADVISORS LLC 4,082 2,333,000 0.08%
ADAR1 Capital Management, LLC 3,963 2,264,845 0.23%
MILLENNIUM MANAGEMENT LLC 3,680 2,103,353 0.0%
HighVista Strategies LLC 3,533 2,019,326 0.98%